Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Cellular Physiology|April 27, 2011
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cellsAntonella De Luca, Marianna Gallo, Donatella Aldinucci, et al.
Frontiers in Oncology|June 20, 2019
Overview of Targeted Drugs for Mature B-Cell Non-hodgkin LymphomasStefania Crisci, Raffaele Di Francia, Sara Mele, et al.
Current Cancer Drug Targets|February 11, 2017
Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted TherapyRaffaele Di Francia, Angela De Monaco, Mariangela Saggese, et al.
International Journal of Cancer|April 25, 2009
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphomaLara Cattaruzza, Annunziata Gloghini, Karin Olivo, et al.
Journal of Translational Medicine|December 2, 2021
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumabRosaria De Filippi, Fortunato Morabito, Armando Santoro, et al.
Infectious Agents and Cancer|August 3, 2022
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantationGianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, et al.
American Journal of Hematology|May 31, 2007
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemiaGiovanni D'Arena, Michela Tarnani, Carlo Rumi, et al.
Cancers|March 6, 2021
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic BiomarkersRaffaele Di Francia, Stefania Crisci, Angela De Monaco, et al.
Annals of Hematology|September 12, 2024
Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatmentFrancesco Volzone, Cristina Becchimanzi, Stefania Crisci, et al.
Haematologica|April 16, 2026
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome during treatment with the bivalent CD20xCD3 bispecific antibody glofitamabAlberto Fresa, Annarosa Cuccaro, Matteo Bonanni, et al.
Pageof 5